Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer.
Leticia Díaz BeltránCarmen González-OlmedoNatalia Luque-CaroCaridad DiazAriadna Martín-BlázquezMónica Fernández-NavarroAna Laura Ortega-GranadosFernando Gálvez-MontosaFrancisca VicenteJosé Pérez Del PalacioPedro Sánchez-RoviraPublished in: Cancers (2021)
Our study identifies metabolic profiling differences in molecular phenotypes of breast cancer. This may represent a key step towards therapy improvement in personalized medicine and prioritization of tailored therapeutic intervention strategies.